Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 10:00PM GMT
Release Date Price: €28.2 (-2.08%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. Good afternoon. We're going to go ahead and get started. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Envista. Breakout's going to be right after across the hall in the Georgian Room.

And with that, let me turn it over to Amir.

Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Pleasure to be here. Thanks for spending time with us. So let me just spend a bit of time, introduce the company to you and then do a deeper dive in some of the challenges and opportunities ahead.

To begin with, I'm sure you all know the routine about the disclaimer, but let me tell you a little bit about what we stand for, about a $2.8 billion business. It came about as an outcome of about 25 acquisitions over a 15-year time period.

56% gross margin, half of it is direct, half of it indirect. And it is really positioned in the best segment of the industry. The macro trends really puts

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot